June 26, 2015

As of June 16, 2015, it has been announced that a collaboration agreement for services and research has been reached between CellResearch Corporation Pte Ltd, a stem cell technology company, and the University of Colorado School of Medicine and ClinImmune Labs, two organizations that are a part of the University of Colorado Anschutz Medical Campus in Aurora, CO. CariCord is part of this medical campus as a US FDA-licensed, cGMP stem cell and umbilical cord blood bank.

The University of Colorado School of Medicine, in addition to having an umbilical cord blood banking service that serves mothers after their pregnancy stages, is one of the top public urban research universities in the United States. It currently has more than 14,000 students on its campus in Downtown Denver, as well as more than 3,000 students in its research and advanced health care programs at the Anschutz Medical Campus in Aurora. Many of these students can answer the question, “What is stem cell research?” and talk to expecting mothers about umbilical cord blood banking during their stages of pregnancy.

CellResearch Corporation Pte Ltd (CRC) was founded in 2002 by a group of clinician scientists and investors in Singapore. CRC is a pioneer and global leader in the field of stem cell research and cord lining stem cells for stem cell regenerative medicine and therapy. CRC is both an inventor and market leader in this sphere. It’s main business purposes are the banking of cord lining stem cells, developing cosmeceuticals in the form of their product, and advanced wound care. Cord blood can be used for anemia treatment in many cases.

The first collaboration will be focused on the development of CRC’s proprietary and patented cord lining mesenchymal stem cells for the treatment of diabetic wounds. Umbilical cord blood banking after a mother’s pregnancy stages can have many uses, including anemia treatment. Dr. Brian Freed, who serves as the Executive Director of ClinImmune Labs and a Professor at the Division of Allergy and Clinical Immunology of the University of Colorado School of Medicine will head the project. He is a leading expert in the field of stem cell therapy, with more than 30 years of experience and 80 publications on the topic.

FaceBook  Twitter  

June 24, 2015

The FDA is very involved with the umbilical cord blood banking process, to ensure that children and families received a high level of care. The FDA has approved cord blood for use in hematopoietic stem cell transplants for treatments that relate to the hematopoietic system. These include certain types of cancers and immune system disorders. Cord blood can also be used for anemia treatment. Cord blood is currently used to treat more than 80 diseases, and stem cell research is widely engaged and constantly developing more treatments.

Private cord blood banks such as CariCord, which store a child’s cord blood after a mother’s pregnancy stages, must abide by regulations set forth by the FDA. These include facility registration, infectious disease testing, donor screening, reporting and labeling, and other standard practices pertaining to umbilical cord blood banking. The FDA does not require approval for cord blood use when it is being donated to a first or second-degree relative of the original donor.

The FDA performs routine inspections of all public and private cord blood banks that collect cord blood after a mother’s pregnancy stages. This is to ensure that the umbilical cord blood banking service is following all of the regulations and guidelines that the FDA has established to protect both the donors and recipients of cord blood banking, which can be used for anemia treatment.

All cord blood banks are required to register with the FDA, but that does not necessarily mean they are FDA-approved. Registration means that an umbilical cord blood banking provider lists their products and methods, among other requirements. However, there are FDA-approved cord blood processing methods (known as a Biologics License Application or BLA) that are used by CariCord’s laboratory, to manufacture cord blood as a pharmaceutical drug for our Public Bank (University of Colorado Cord Blood Bank). CariCord, the private family bank has taken things a step further than other private banks, because we use the identical methods and the same lab to process private cord blood units. Expectant mothers in their stages of pregnancy can be confident, because an FDA-approved process is employed to insure the best quality possible for our Private banking clients.

CariCord is the only private bank using FDA BLA approved processing methodology. No other private bank can make this claim.

FaceBook  Twitter  

June 22, 2015

Those who are new to umbilical cord blood banking often ask questions like “What is stem cell research?” and “What if I’m adopting a child?” These are excellent questions that should be answered while you are still in your earlier stages of pregnancy, as cord blood banking must be decided upon by expecting mothers before their pregnancy stages are completed.

For families, umbilical cord blood banking is an excellent option to consider during their stages of pregnancy, especially if there is a history of disease in the family. However, cord blood banking can be especially critical if you are adopting a child, since many families who adopt are unsure of the health history of the child’s biological family.

If you are adopting a child (that hasn’t been born yet), the enrollment process for umbilical cord blood banking through CariCord is essentially the same. The only difference is the birth mother should be the one to fill out the medical history forms and provide a maternal blood sample, which will be tested for any infectious diseases. Aside from that, the cord blood banking process is the same!

Because many adoptive parents do not know the family medical history of the family from which they are adopting, they are more open to consider cord blood banking while the birth mother is undergoing her stages of pregnancy. With traditional families, it is relatively easy to use a sibling’s stem cells down the road in the event of an unexpected illness. But with adoption, there is often an uncertainty of whether a sibling will be available down the road, and umbilical cord blood banking ensures that the child will have the best possible chance for a stem cell match, should cord blood ever be needed for anemia treatment or treatment of another disease in the future.

Whether you adopting or having a child of your own, CariCord encourages all expecting mothers to consider cord blood banking during their stages of pregnancy. Currently, cord blood can be used to treat more than 80 diseases, including anemia treatment, and stem cell researchers are continually finding new uses for cord blood.

FaceBook  Twitter  

June 19, 2015

Umbilical cord blood banking is an important component to stem cell research, allowing cord blood cells that are collected from a new mother at birth, after her stages of pregnancy, to be used for a variety of purposes, including anemia treatment and the treatment of many other diseases.

When it comes to cord blood, expecting mothers have three options to consider during their pregnancy stages. A decision must be made during one’s stages of pregnancy, because umbilical cord blood banking can only be done at the birth of a child.

The first option is to store the newborn’s cord blood through a private cord blood banking service. This option makes the cord blood available exclusively to the family, in the event that it is ever needed for that child or another family member. Cord blood can be used to treat a variety of diseases, including various cancers, leukemia, and anemia treatment.

The second option is for new mothers to donate their child’s cord blood to a public cord blood bank after they complete their stages of pregnancy and give birth to their child. The cord blood will be collected by the doctor after delivery of their baby and donated to a public cord blood bank to be used for stem cell research, or to donate to a person in need who is a sufficient match.

The third option is, unfortunately, the most common. This option is to make no decision regarding cord blood banking during pregnancy stages. With this option, the otherwise useful cord blood will be discarded as medical waste.

As more and more expecting parents learn of the value of public and private umbilical cord blood banking, they are choosing one of the first two options over the third. CariCord is proud to offer private family banking, as well as public cord blood banking through our partners. Regardless of which you choose, you can be proud to know that your child’s cord blood will be put to good use, or stored for future use in the event that it is needed.

FaceBook  Twitter